Du L - Search Results

1

Advances in mRNA and other vaccines against MERS-CoV.

Tai W, Zhang X, Yang Y, Zhu J, Du L. Tai W, et al. Among authors: du l. Transl Res. 2022 Apr;242:20-37. doi: 10.1016/j.trsl.2021.11.007. Epub 2021 Nov 19. Transl Res. 2022. PMID: 34801748 Free PMC article. Review.

2

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. Du L, et al. Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9. Nat Rev Microbiol. 2009. PMID: 19198616 Free PMC article. Review.

3

Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.

Du L, Zhao G, Chan CC, Sun S, Chen M, Liu Z, Guo H, He Y, Zhou Y, Zheng BJ, Jiang S. Du L, et al. Virology. 2009 Oct 10;393(1):144-50. doi: 10.1016/j.virol.2009.07.018. Epub 2009 Aug 15. Virology. 2009. PMID: 19683779 Free PMC article.

4

A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity.

Du L, Zhao G, Chan CC, Li L, He Y, Zhou Y, Zheng BJ, Jiang S. Du L, et al. Viral Immunol. 2010 Apr;23(2):211-9. doi: 10.1089/vim.2009.0090. Viral Immunol. 2010. PMID: 20374001 Free PMC article.

5

Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies.

Du L, Zhao G, Zhang X, Liu Z, Yu H, Zheng BJ, Zhou Y, Jiang S. Du L, et al. Biochem Biophys Res Commun. 2010 Jul 2;397(3):580-5. doi: 10.1016/j.bbrc.2010.05.161. Biochem Biophys Res Commun. 2010. PMID: 20617558 Free PMC article.

6

A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses.

Du L, Leung VH, Zhang X, Zhou J, Chen M, He W, Zhang HY, Chan CC, Poon VK, Zhao G, Sun S, Cai L, Zhou Y, Zheng BJ, Jiang S. Du L, et al. PLoS One. 2011 Jan 27;6(1):e16555. doi: 10.1371/journal.pone.0016555. PLoS One. 2011. PMID: 21304591 Free PMC article.

7

Protocol for recombinant RBD-based SARS vaccines: protein preparation, animal vaccination and neutralization detection.

Du L, Zhang X, Liu J, Jiang S. Du L, et al. J Vis Exp. 2011 May 2;(51):2444. doi: 10.3791/2444. J Vis Exp. 2011. PMID: 21587153 Free PMC article.

8

A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.

Du L, Zhao G, Sun S, Zhang X, Zhou X, Guo Y, Li Y, Zhou Y, Jiang S. Du L, et al. PLoS One. 2013;8(1):e53568. doi: 10.1371/journal.pone.0053568. Epub 2013 Jan 8. PLoS One. 2013. PMID: 23320093 Free PMC article.

9

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines.

Du L, Kou Z, Ma C, Tao X, Wang L, Zhao G, Chen Y, Yu F, Tseng CT, Zhou Y, Jiang S. Du L, et al. PLoS One. 2013 Dec 4;8(12):e81587. doi: 10.1371/journal.pone.0081587. eCollection 2013. PLoS One. 2013. PMID: 24324708 Free PMC article.

10

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.

Ma C, Li Y, Wang L, Zhao G, Tao X, Tseng CT, Zhou Y, Du L, Jiang S. Ma C, et al. Among authors: du l. Vaccine. 2014 Apr 11;32(18):2100-8. doi: 10.1016/j.vaccine.2014.02.004. Epub 2014 Feb 18. Vaccine. 2014. PMID: 24560617 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,145 results

Search Page

Filters